Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of cinnamaldehyde in preparation of drugs for targeted therapy of bacterial infection

A bacterial infection and targeted therapy technology, applied in the field of medicine, can solve the problems of difficult clinical infectious diseases, bacterial infection, untimely treatment, etc.

Active Publication Date: 2017-01-25
THE SECOND HOSPITAL OF HEBEI MEDICAL UNIV
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The emergence of multi-drug resistant bacteria and outbreaks in hospital environments have made the treatment of clinical infectious diseases more difficult, with poor prognosis and increased mortality, especially for patients with immunodeficiency such as blood diseases, tumors, and organ transplants. Due to the limited choice of drugs for multi-drug resistant bacteria, such as CR-ABA, which is often only sensitive to polymyxin, and this drug is not available in China, many infections caused by this bacteria, especially for patients with bloodstream infections because there are almost no drugs available, Death due to untimely treatment; at the same time, multi-drug resistant bacteria are very easy to break out in the hospital environment, so this kind of bacteria has become a major problem in the clinical work of the hospital. In view of this, the development of safe, efficient and sensitive drugs has become a An urgent priority for the control and treatment of multidrug-resistant bacterial infections

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of cinnamaldehyde in preparation of drugs for targeted therapy of bacterial infection
  • Application of cinnamaldehyde in preparation of drugs for targeted therapy of bacterial infection
  • Application of cinnamaldehyde in preparation of drugs for targeted therapy of bacterial infection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1 is cinnamaldehyde 1.25, Tween-80 0.05g.

[0036]1. Methods: 30 strains of non-repeated multidrug-resistant bacteria isolated from inpatients in the Second Hospital of Hebei Medical University were selected, including methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Acinetobacter baumannii (CR-ABA), carbapenem-resistant Klebsiella pneumoniae (CRE), carbapenem-resistant Pseudomonas aeruginosa (CR-PAE), vancomycin-resistant Enterococcus (VRE). At the same time, 28 strains of each of the above five non-multidrug-resistant Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterococcus faecium were selected to compare the effects of cinnamic aldehyde on the above bacteria. Effect.

[0037] Quality control strains: ATCC25922, ATCC25923, ATCC29212, ATCC27853.

[0038] 2. Results:

[0039] The results show that cinnamaldehyde has good sensitivity to multi-drug resistant bacteria, see Table 1

...

Embodiment 2

[0045] Embodiment 2 cinnamic aldehyde monomer clathrate of the present invention

[0046] Composition: Cinnamaldehyde 1.25g (50 parts by weight)

[0047] 2-hydroxypropyl-β-cyclodextrin 1.25g (50 parts by weight)

[0048] Preparation:

[0049] 1) Add 2-hydroxypropyl-β-cyclodextrin to 80°C deionized distilled water, stir to dissolve, then cool down to 20°C to prepare an aqueous solution for use; among them, 2-hydroxypropyl-β-cyclodextrin The weight mg / volume mL ratio of essence and deionized distilled water is 1:10;

[0050] 2) Under stirring, slowly add cinnamon aldehyde dissolved in ethyl acetate dropwise to the aqueous solution obtained in step 1). After the dropwise addition, raise the temperature to 70°C and continue stirring for 1 hour, then refrigerate for 24 hours to obtain a refrigerated solution , standby; wherein, the volume mL ratio of cinnamaldehyde to ethyl acetate is 1:6;

[0051] 3) Filter the refrigerated liquid obtained in step 2), wash the solid matter wit...

Embodiment 3

[0051] 3) Filter the refrigerated liquid obtained in step 2), wash the solid matter with a small amount of distilled water, dry it in vacuum at a low temperature of 5°C for 24 hours, grind it, sieve it through 80 mesh, wash it with ethyl acetate three times, and dry it in the air to obtain white Loose cinnamaldehyde monomer inclusion compound. Embodiment 3 cinnamic aldehyde monomer clathrate of the present invention

[0052] Composition: Cinnamaldehyde 1g (10 parts by weight)

[0053] 2-hydroxypropyl-β-cyclodextrin 2g (20 parts by weight)

[0054] Preparation method: with embodiment 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of cinnamaldehyde in preparation of drugs for targeted therapy of bacterial infection, and belongs to the technical field of medicines. Bacteria are multi-drug-resistant bacteria such as methicillin-resistant staphylococcus aureus, carbapenem-resistant baumanii, carbapenem-resistant enterobacteriaceae, carbapenem-resistant pseudomonas aeruginosa or vancomycin-resistant enterococcus. By the research result of the invention, an efficient, low-toxicity and novel antibacterial medicine which is used for targeted therapy of multi-drug-resistant bacterial infection is provided for bacterial infection of departments such as a clinical pneumology department, a hematology department, an emergency treatment ICU, an oncology department and organ grafting, in-vivo pharmacodynamics, an action mechanism and a theoretical experiment basis are provided for research and development of traditional Chinese medicines for treating multi-drug-resistant bacterial infection, and conditions are created for transformation of scientific achievements.

Description

technical field [0001] The invention relates to the application of an active ingredient in the preparation of medicines, more specifically, relates to the application of cinnamaldehyde in the preparation of medicines for targeted treatment of bacterial infections, and belongs to the technical field of medicine. Background technique [0002] In recent years, due to the wide application of broad-spectrum antibiotics, multidrug-resistant bacterial infections in hospitals have increased year by year. In 2014, the monitoring data of China Hospital Antimicrobial Resistance Surveillance Network (CHINET) showed that MRSA is currently in 18 major hospitals in my country. Hospital incidence was 30-73%, 62-70% for carbapenem-resistant Acinetobacter baumannii (CR-ABA), and 24% for carbapenem-resistant Pseudomonas aeruginosa (CR-PAE) -26%, carbapenem-resistant Klebsiella pneumoniae (CR-KPN) was 10-13%, and vancomycin-resistant enterococcus (VRE) was 3-4%. The emergence of multi-drug resis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/11A61K47/69A61K47/26A61P31/04
CPCA61K31/11A61K47/26
Inventor 王刚生邓洁华李继红张朝军赵宜乐
Owner THE SECOND HOSPITAL OF HEBEI MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com